Herbalife Ltd.

-$0.25 (-0.6%)
Closing price September 20, 2021
Herbalife raised its second-quarter and full-year EPS guidance Monday morning, at the same time that it warned that sales could be lower due to last year's settlement with the FTC.
Herbalife reported better-than-expected first-quarter financial results after the markets closed on Thursday.
Another week in which the relentless strength of the stock market continued, and again this week, insider buying remained stronger than we have seen for most of the first quarter.
Herbalife has been more than a controversial stock over the past three years or more. Short seller and activist investor Bill Ackman had roughly a $1 billion bet against this company and has been a...
Herbalife beats profit estimates and meets revenues targets, but the outlook fails to impress investors.
The broad markets are continuing to hit new highs even though the fourth quarter earnings season is over. Although there are a few more companies reporting this week. 24/7 Wall St. has put together a...
Although earnings season is done for the most part, there are still some key companies left to report in the coming week, and these could potentially help push the markets to new highs.
After a dramatic conclusion to the presidential race, insider buying was dramatically larger than we have seen in months, and it could continue the rest of the year.
Carl Icahn believes that Herbalife might be better off as a privately held firm and he has weighed the possibility of launching a tender offer for it.
With volume picking up as traders return from the Labor Day holiday, it should be no surprise that insider volume picked up as well.
One thing is for sure, the insiders continue to buy stock, and at these lofty levels, that remains a positive for investors.
Stocks overall were fractionally higher early on Monday, August 29, 2016. That makes the big percentages gainers and losers and the companies with big headline news stand out even more.
24/7 Wall St. has put together a preview of Pfizer, Chesapeake Energy and other major companies reporting their quarterly results this week.
Herbalife is treating this settlement as a victory. The question now is whether it will begin to aggressively go after Bill Ackman for calling Herbalife a pyramid scheme.
Janus Capital has now launched the Obesity ETF, which has a strategy of investing in companies that provide treatment and care for obesity and obesity‐related disease.